or Try an Advanced Search...

    Technical Analysis for ALZN - Alzamend Neuro, Inc.

    Grade Last Price % Change Price Change
    F 0.69 -0.16% 0.00
    ALZN closed down 4.57 percent on Thursday, April 18, 2024, on 42 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical ALZN trend table...
    Date Alert Name Type % Chg
    New Downtrend Bearish -0.16%
    NR7 Range Contraction -0.16%
    Narrow Range Bar Range Contraction -0.16%
    Lower Bollinger Band Walk Weakness -0.16%
    Wide Bands Range Expansion -0.16%
    Lower Bollinger Band Touch Weakness -0.16%
    Oversold Stochastic Weakness -0.16%
    Fell Below 200 DMA Bearish -4.72%
    Stochastic Buy Signal Bullish -4.72%
    Lower Bollinger Band Walk Weakness -4.72%
    Older End-of-Day Signals for ALZN ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 12 minutes ago
    Possible Inside Day 12 minutes ago
    Gap Up Closed 31 minutes ago
    60 Minute Opening Range Breakdown 31 minutes ago
    Reversed from Up 31 minutes ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    ALZN Chart by TradingView
    Basic chart:

    Profile

    Alzamend Neuro, Inc., a preclinical stage biopharmaceutical company, focuses on developing products for the treatment of neurodegenerative diseases and psychiatric disorders. The company's lead product candidate is AL001 for the treatment of Alzheimer's and other neurodegenerative diseases and psychiatric disorders. It is also developing AL002, a cell-based therapeutic vaccine, which seeks to restore the ability of the patient's immunological system to Alzheimer's. The company was incorporated in 2016 and is headquartered in Tampa, Florida.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Life Sciences Biology Medication Neuroscience Alzheimer's Disease Dementia Neurodegenerative Diseases Psychiatric Diagnosis Amyloidosis Neurodegeneration Preclinical Stage Biopharmaceutical Psychiatric Disorders Treatment Of Neurodegenerative Diseases Treatment Of Alzheimer's

    Is ALZN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 4 Aldeyra Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
    Apr 2 Insiders Are Buying These 11 Penny Stocks
    Apr 2 Silo Pharma And 3 Other Stocks Under $5 Insiders Are Buying
    Jan 10 Alzamend Neuro And 3 Other Stocks Under $3 Insiders Are Buying
    Dec 11 EXCLUSIVE: Alzamend Neuro Plans To Kickstart Stress Disorder Study With Next-Gen Lithium Product Next Year
    Dec 11 Alzamend gets FDA letter for initiating Phase IIA study of lithium therapeutic drug candidate
    Dec 11 Alzamend Neuro Receives FDA "Study May Proceed" Notification for a Phase IIA Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, in Post-Traumatic Stress Disorder Patients
    Nov 21 Alzamend stock tumbles 18% in wake of clinical study update
    Nov 20 Alzamend Neuro Receives FDA "Study May Proceed" Notification for a Phase IIA Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, in Major Depressive Disorder Patients
    Nov 16 Alzamend Neuro Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
    See more ALZN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.032
    52 Week Low 0.1132
    Average Volume 64,163
    200-Day Moving Average 0.73
    50-Day Moving Average 0.94
    20-Day Moving Average 0.90
    10-Day Moving Average 0.82
    Average True Range 0.08
    RSI (14) 30.07
    ADX 26.68
    +DI 8.39
    -DI 27.09
    Chandelier Exit (Long, 3 ATRs) 0.87
    Chandelier Exit (Short, 3 ATRs) 0.91
    Upper Bollinger Bands 1.11
    Lower Bollinger Band 0.69
    Percent B (%b) 0.01
    BandWidth 46.78
    MACD Line -0.07
    MACD Signal Line -0.04
    MACD Histogram -0.0241
    Fundamentals Value
    Market Cap 4.57 Million
    Num Shares 6.62 Million
    EPS -2.28
    Price-to-Earnings (P/E) Ratio -0.30
    Price-to-Sales 0.00
    Price-to-Book 7.23
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.75
    Resistance 3 (R3) 0.75 0.73 0.74
    Resistance 2 (R2) 0.73 0.72 0.73 0.73
    Resistance 1 (R1) 0.71 0.71 0.71 0.71 0.73
    Pivot Point 0.70 0.70 0.69 0.70 0.70
    Support 1 (S1) 0.68 0.68 0.67 0.67 0.65
    Support 2 (S2) 0.66 0.68 0.66 0.65
    Support 3 (S3) 0.64 0.66 0.65
    Support 4 (S4) 0.64